Re: heard back from Sarah..
|
3
|
Resverlogix Corp.
|
Oct 04, 2021 03:04PM
|
from IR "Hepalink does not own Zenith shares."
|
3
|
Zenith Epigenetics
|
Oct 24, 2022 02:25PM
|
Re: If we make it back to 2.00,
|
3
|
Resverlogix Corp.
|
Nov 13, 2019 04:29PM
|
Re: Surprise
|
3
|
Resverlogix Corp.
|
Nov 29, 2019 10:49AM
|
Re: Drugmakers, scientists begin the hunt for long COVID treatments
|
4
|
Resverlogix Corp.
|
Mar 28, 2022 10:01AM
|
Re: Good open...
|
4
|
Resverlogix Corp.
|
Nov 18, 2019 09:51AM
|
Re: Thanks!
|
4
|
Resverlogix Corp.
|
Sep 24, 2021 02:56PM
|
Re: I'm seeing another pennant/flag....
|
4
|
Resverlogix Corp.
|
Jul 23, 2019 03:02PM
|
Re: Thanks!
|
4
|
Resverlogix Corp.
|
Sep 24, 2021 03:07PM
|
well, less that 24hr to give that back ....& more
|
4
|
Resverlogix Corp.
|
Mar 04, 2021 02:34PM
|
In the near term we will continue our multi-point approach to progressing our corporate commercial value. This approach involves aggressive explorator
|
4
|
Resverlogix Corp.
|
Dec 06, 2019 08:30AM
|
Re: Share Price...
|
4
|
Resverlogix Corp.
|
Apr 02, 2020 03:52PM
|
Re: Update from IR -- Eversana paused?
|
4
|
Resverlogix Corp.
|
Dec 21, 2022 06:12PM
|
one more reason
|
4
|
Resverlogix Corp.
|
Sep 24, 2021 03:46PM
|
Re: Q1- March 31, 2022 on SEDAR
|
4
|
Resverlogix Corp.
|
May 16, 2022 06:32PM
|
Re: Warning: Long - Thoughts on Management
|
4
|
Resverlogix Corp.
|
Mar 26, 2021 01:01PM
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
4
|
Resverlogix Corp.
|
Mar 24, 2020 09:33AM
|
Re: A Second Publication Shortlists Resverlogix Clinical Candidate Apabetalone for its Potential COVID-19 Effectiveness Including Reducing Cytokine Storms
|
4
|
Resverlogix Corp.
|
Oct 26, 2020 08:26AM
|
Re: Margin calls
|
4
|
Resverlogix Corp.
|
Mar 11, 2020 01:57PM
|
Re: Thar she blows!
|
4
|
Resverlogix Corp.
|
May 20, 2021 10:00AM
|